Record type
Research Payment
Payment amount $300,000.00
Date of payment March 15, 2021
| Expenditure category | N/A |
|---|---|
| Form of payment | Cash or cash equivalent |
| Reporting year | 2021 |
| Open Payments Record ID | 832925037 |
| Disputed by recipient | No |
| Reporting Company | PFIZER INC. New York United States |
|---|---|
| Company submitting payment information | Pfizer Inc. |
| Recipient name | THE UNIVERSITY OF TEXAS MEDICAL BR. |
|---|---|
| Recipient type | Covered Recipient Teaching Hospital |
| Provider type (primary) | N/A |
| Specialty | N/A |
| State license | N/A |
| Payment associated with Pre-Clinical research? | No |
|---|---|
| Name of research study | REPORTER SARSCOV2 VIRUS NEUTRALIZATION ASSAY |
| Principal investigators | |
| ClinicalTrials.gov ID | |
| Link to research study | N/A |
Additional information (provided by company making payment)
N/A
Disclaimer
Data is reported on this website in accordance with the statutory authority in Section 1128 G of the Social Security Act. CMS has an impartial role in the collection and reporting of data regarding payments or other transfers of value pursuant to Open Payments. The transparency display of transactions from applicable manufacturers and group purchasing organizations to physicians, physician assistants, advanced practice nurses, and teaching hospitals does not necessarily mean any of the reported financial relationships are improper.
Report violations
If you have knowledge of a possible Open Payments reporting violation, please contact opcompliance@cms.hhs.gov.